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Abstract: Tumour thrombosis is a relatively rare complication of solid cancers, with occult inferior vena cava(IVC) 
tumour thrombosis having a reported incidence rate of 0.11%. Renal cell carcinoma(RCC) has a propensity to extend as 
tumour thrombus into the renal vein and IVC. The preoperative assessment for the presence and extent of renal vein 
and IVC tumour thrombus is important for planning appropriate surgical resection. There are reports having described 
the diagnosis of tumour thrombosis by Fluorine-18 fluorodeoxyglucose positron emission tomography and Computed 
tomography (F-18 FDG PET/CT). We present two cases, one with right RCC showing renal vein and IVC tumour 
invasion and another left RCC with renal vein, IVC and hepatic vein thrombosis detected using FDG PET/CT. 
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INTRODUCTION 
Tumour thrombus is one of the rare complications of 
renal cell carcinoma (RCC), Wilm’s tumour, testicular 
tumour, adrenal cortical carcinoma, lymphoma, 
pancreatic cancer, osteosarcoma, Ewing’s sarcoma 
and hepatocellular carcinoma [1]. RCC is an 
aggressive neoplasm with potential dissemination to 
the renal veins and IVC in 24% and 12% of all cases, 
respectively [2]. In a few instances, RCC venous 
extension may go beyond the IVC, reaching the hepatic 
vein and even right atrium. RCC venous involvement 
carries a serious outcome prognosis and necessitates 
an in-depth imaging evaluation and staging before 
surgery and thrombectomy [3]. The diagnosis is usually 
made accidentally during staging investigations. 
Recent introduction of FDG PET/CT technology has 
revolutionized by fusing functional and anatomical 
criteria for staging of most cancers, thus allowing 
accurate anatomical localization of tumour spread and 
providing the ability to differentiate between tumour and 
blood thrombus [4]. 
CASE 1 
60 yr old male presented with pain in left flank, loss 
of weight for 3 weeks. He underwent Contrast 
enhanced CT abdomen for suspicion of RCC which 
revealed left renal mass with thrombosis in left renal 
vein and IVC. FDG PET/CT was performed for staging 
and differentiating tumour thrombus and bland 
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thrombus. Diffuse FDG uptake extending from the left 
kidney medially and superiorly to the level of the 
diaphragm corresponded with IVC abnormalities on 
CT. FDG uptake on PET/CT supported the presence of 
tumour thrombus in the left renal vein and IVC. The 
patient underwent a thoraco-abdominal nephrectomy, 
with RCC and thrombus in the left hepatic vein and IVC 
confirmed during surgery. 
CASE 2 
71 yrs old male presented with left flank pain for1 
week. He underwent Contrast enhanced CT abdomen 
which revealed lobulated hypodense lesion at the 
upper pole of left kidney with enlarged IVC and left 
renal vein suggestive of thrombosis. He was referred 
for FDG PET/CT for initial staging which showed 
intense FDG uptake in the upper pole of left kidney with 
extending medially and superiorly to the level of the 
diaphragm and in the liver which supported the 
diagnosis of left renal vein, IVC and unsuspected right 
hepatic vein thrombosis. He underwent nephrectomy 
with tumour thrombus removal in IVC and hepatic vein. 
DISCUSSION 
Venous thromboembolism (VTE) is a well-
recognized and relatively frequent complication of 
malignancy. Tumour thrombosis, in contrast, is a rare 
complication of solid cancers such as colon, pancreas, 
hepatocellular carcinoma and RCC, and has also been 
described in lymphoma and sarcoma [4].
 
The correct 
diagnosis of tumour thrombosis and its differentiation 
from VTE can alter patient management and prevent 
unnecessary long-term anticoagulation treatment. RCC


















Figure 1. Coronal CT, PET, Fused FDG PET/CT and Maximum intensity projection (MIP) images. 
(A) after intravenous administration of 10 mCi of F-18 FDG demonstrate a rim of enhanced FDG uptake surrounding a 
photopenic mass in the upper part right kidney. Additional activity extending medially and superiorly to the level of the 
diaphragm.  
Axial images (B) from Fused FDG PET/CT demonstrate enhanced FDG uptake in a dilated segment of the inferior vena cava. 
The enhanced FDG activity on PET/CT with maximum standardized uptake value (SUVmax) of 21 with heterogeneous material 
in a dilated inferior vena cava, suggesting tumour thrombus. 
Axial images (C) from fused FDG PET/CT demonstrate another focus of increased uptake to the unsuspected nodule in the left 
lower lobe of lung suggestive of metastasis. 
is an aggressive neoplasm with potential dissemination 
to the renal veins and IVC in 24% and 12% of all 
cases, respectively [5]. Accurate tumour staging in 
patients with RCC is essential before surgical 
management. Extension of tumour thrombus into the 
renal vein or IVC is a known complication of RCC with 
significant prognostic and therapeutic implications. 
Thrombus extension above the diaphragm and into the 
right atrium may require thoracotomy and resection of 
affected vena cava segments in addition to 
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Figure 2. Coronal CT, PET, Fused FDG PET/CT and Maximum intensity projection (MIP) images (A) demonstrate intense FDG 
uptake in the upper pole of left kidney. Additional activity extending medially and superiorly to the level of the diaphragm and into 
liver is also seen. Another focus is noted in right hilar region suggestive of mediastinal nodal metastasis. 
Axial images (B) from fused FDG PET/CT demonstrate intense FDG uptake in a dilated segment of the IVC. FDG activity on 
FDG PET/CT with maximum standardized uptake value (SUVmax) of 34 corresponds to CT findings of dilated left renal vein and 
IVC suggesting tumour thrombus. Also vertebral uptake showing bone metastasis. 
Axial images (C) of fused PET/CT shows FDG uptake with maximum standardized uptake value (SUVmax) of 24 in the liver 
which corresponds to the right hepatic vein suggestive of thrombosis. 
nephrectomy [6].
 
Patients with RCC may also be 
hypercoagulable and develop bland caval thrombus 
that may not require caval resection or thrombectomy. 
Distinguishing between these 2 entities is not usually 
possible with enhanced computerized tomography (CT) 
or magnetic resonance imaging [7].
 
FDG PET/CT imaging is limited in the identification 
of primary urologic neoplasms resulting from the 
proximity of physiological radiotracer uptake in the 
normal genitourinary system. However, FDG PET/CT is 
capable of detecting regional and distant urologic 
metastases presenting with a better target-to-
background signal ratio away from physiological foci of 
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F-18 FDG accumulation [8]. Only sporadic reports have 
described the diagnosis of tumour thrombosis by 
positron emission tomography with 18F-
fluorodeoxyglucose [9,10]. Positive FDG PET/CT 
demonstration of venous tumour thrombus has been 
previously reported in IVC related to RCC [11] Although 
only limited data exist in the literature, it appears that 
18F-FDG-PET scans can be used to accurately 
differentiate between septic and aseptic deep vein 
thrombosis [12]. Septic lesions have increased uptake 
of 18-FDG, whereas aseptic deep vein thromboses 
have been reported to exhibit normal biodistribution of 
the agent. These findings were the basis for the 
assumption that FDG imaging by PET/CT may 
differentiate between tumour thrombosis and VTE as 
well. Davidson et al. [13] described Accuracy of FDG 
PET/CT to differentiate between tumour thrombosis 
and benign VTE was 100% in a small study. Sharma 
et al. [14] recently described 24 patients with tumour 
thrombus of different etiology and concluded that the 
mean maximum standardized uptake value (SUVmax) 
was 3.2 (range: 2.3-4.6; median: 3.3) in the benign 
thrombosis group and was 6.0 (range: 2.3- 13.8; 
median: 3.3) in the tumour thrombosis group and FDG 
PET-CT can detect active tumour thrombosis and is 
helpful in differentiating it from benign thrombus. Our 
patients had SUVmax of 21 and 34 which help in 
accurately differentiate tumour thrombus. 
CONCLUSION 
FDG PET/CT accurately differentiated tumour 
thrombosis from benign venous thrombi in our patients. 
FDG PET/ CT appears to be beneficial in the diagnosis 
of occult tumour thrombosis and may be used as a 
non-invasive tool to characterize suspicious thrombotic 
lesions, both above and below the diaphragm. By 
furthering the diagnosis and recognition of tumour 
thrombi by PET/CT may consequently improve patient 
management. These case serves as a reminder that 
special attention should always be paid to the IVC and 
adjoining venous drainage pathways for abnormal FDG 
activity, particularly when imaging RCC, as the 
diagnosis of venous tumour thrombus has important 
clinical ramifications. 
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